PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
May 02, 2024 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call...
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
April 25, 2024 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet...
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
April 23, 2024 09:00 ET
|
Diamond Equity Research LLC; ProPhase Labs Inc.
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase...
ProPhase Labs Unveils Project ZenQ-AI
April 16, 2024 08:00 ET
|
ProPhase Labs, Inc.
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City, NY, April 16, 2024 (GLOBE NEWSWIRE)...
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
April 10, 2024 08:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 10, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today reported its...
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024 21:00 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 01, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biopharma, genomics, and diagnostics company, today announced...
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
March 18, 2024 09:08 ET
|
Diamond Equity Research LLC; ProPhase Labs Inc.
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on ProPhase...
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
March 15, 2024 08:00 ET
|
ProPhase Labs, Inc.
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion – set for rapid...
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
March 08, 2024 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting full year 2023 financial results on a virtual conference call...
Global Clinical Medical Laboratory Services Market Analysis Report 2024-2028: Infectious Disease Diagnostics Becomes a Growth Industry, Explosion in Biotechnological Advancements
February 27, 2024 04:26 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Medical Laboratory Services Market - Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country....